세계의 분기 스텐트 그래프트 시장 규모는 2023년에 3억 2,439만 달러로 평가되었고, 2024년 3억 4,937만 달러에서 2032년에는 6억 3,242만 달러로 성장할 전망이며, 예측 기간 2025년부터 2032년까지 CAGR은 7.7%에서 발전할 전망입니다.
분기 스텐트 그래프트 시장은 처음에는 대동맥 병변의 치료용으로 개발되었지만, 혈관내 대동맥 수복술(EVAR) 증가나 환자 케어의 기술 진보에 의해 큰 성장을 이루고 있습니다. 이 혁신적인 치료는 대흉동맥류나 동맥해리에 대한 EVAR의 적용을 확대하고, 특히 고령화 사회에서의 대동맥류나 복부동맥류의 유병률 상승에 대처하고 있습니다. 하지만 코로나19 팬데믹 발생이 시장 진전을 방해하면서 매출 감소와 대기적 수술 지연으로 이어졌다. 이러한 과제에도 불구하고 저침습 수술에 대한 수요가 증가함에 따라 시장은 회복되고 있으며, 향후 몇 년간은 시장 확대의 큰 기회가 될 것입니다.
Global Branched Stent Grafts Market size was valued at USD 324.39 Million in 2023 and is poised to grow from USD 349.37 Million in 2024 to USD 632.42 Million by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).
The branched stent graft market, initially developed for treating aortic lesions, is experiencing significant growth due to an increasing number of endovascular aortic repair (EVAR) procedures and technological advancements in patient care. This innovative treatment expands EVAR applications for pectoral aneurysms and arterial dissections, addressing the rising prevalence of aortic and abdominal aneurysms, particularly among the aging population. However, the onset of the COVID-19 pandemic hindered market progress, leading to decreased sales and delayed elective surgeries. Despite these challenges, the market is poised for recovery, driven by a growing demand for minimally invasive surgical options, which presents substantial opportunities for market expansion in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Branched Stent Grafts Market Segmental Analysis
Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Branched Stent Grafts Market
The Global Branched Stent Grafts market is experiencing significant growth, primarily driven by the increasing number of endovascular aneurysm repair (EVAR) procedures. This uptick can be attributed to enhancements in patient care quality and continual advancements in medical technology, which improve procedural outcomes. Additionally, the ageing population is a crucial factor contributing to market expansion, as older individuals are more susceptible to health issues such as abdominal aortic aneurysms (AAA). Consequently, the combination of these elements is fostering a conducive environment for the continued development and adoption of branched stent grafts within the healthcare landscape.
Restraints in the Global Branched Stent Grafts Market
The Global Branched Stent Grafts market faces significant challenges due to high costs associated with endovascular aneurysm repair procedures. These expenses often render such treatments unaffordable for middle- and lower-income individuals, limiting their access to vital medical interventions. As a result, the financial burden acts as a major restraint on the growth of the branched stent grafts market, as many potential patients may opt for alternative, less costly options or forego treatment altogether. This financial barrier ultimately impacts market demand and hinders the overall expansion of branched stent graft technologies within the healthcare landscape.
Market Trends of the Global Branched Stent Grafts Market
The Global Branched Stent Grafts market is witnessing significant growth driven by the increasing adoption of minimally invasive procedures like AEVAR, BEVAR, and TEVAR for aneurysm treatment. These advanced techniques offer patients safety, efficacy, and cost-effectiveness, appealing to both healthcare providers and patients alike. The demand for Image guidance technologies, such as X-rays, further enhances procedural success, solidifying branched stent grafts as essential tools in vascular interventions. As awareness of vascular diseases grows and technology advances, the market for branched stent grafts is poised for expansion, making it a key area of investment for medical device manufacturers and healthcare providers globally.